New biomarker identified in breast, prostate cancers holds promise for treating disease

Researchers have identified a novel genetic biomarker responsible for the progression of many breast and prostate cancers. The finding could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs, they say. —> Read More